It has been demonstrated to interact with the key tumor suppressor protein p53, functionally inactivated in a large majority of cancers (Wadhwa et al., 1998; Benbrook et al., 2014; Sane et al., 2014; Pham et al., 2019; Benbrook, 2022). The gene discussed is TP53; the disease is cancer.